CEO Pascal Soriot reflects on AstraZeneca's H1 2019 Results Published 2019-07-24 Download video MP4 360p Download video MP4 720p Recommendations 00:59 AstraZeneca half-year 2019 Results animation 03:55 BioPharmaceuticals Medical: Transforming Care 01:27 Discover a culture of lifelong learning at AstraZeneca 06:35 Career advice for women in the workplace 00:33 The Ideal AstraZeneca Candidate 08:31 The challenges women face in the work place 03:46 Living with Transthyretin Amyloidosis (ATTR) 02:36 The next chapter for Healthy Heart Africa 07:59 Susan Galbraith: Driving innovation in cancer research 02:00 Inspiring futures: impact of STEM on women and girls 02:56 Personalised Medicine Makes a Difference in Lung Cancer Diagnosis 00:31 AstraZeneca sets ambition to deliver $80 billion annual by 2030 02:56 Research collaboration to advance innovative solutions for patients with neurological diseases 00:47 AstraZeneca Barcelona, Great Place to Work, Great Place to Be 01:50 Oncology R&D strategy - attacking cancer from multiple angles 02:25 CoSolve 2023 announces collaboration with the Moss group 01:10 Trailblazing science: bispecific antibodies & immune cell engagers 06:44 Women in leadership 01:09 How do TCR-Ts differ from CAR-T cell therapies? 01:03 Full Year and Q4 2023 Results Similar videos 00:19 Pascal Soriot thanks our people for their commitment and passion 04:53 CEO Pascal Soriot in conversation with Mene Pangalos, EVP, BioPharmaceuticals R&D 14:34 Vaccinating the world with AstraZeneca CEO, Pascal Soriot 09:06 AstraZeneca CEO Sees Covid Vaccine on Track for Year End 04:51 First-quarter 2020: Delivering strong results, fighting COVID-19 01:07 Full Year and Q4 2022 results 05:03 AstraZeneca CEO: Objective is to replace chemotherapy 01:11 Pascal Soriot : l’incroyable parcours du (discret) patron d'AstraZeneca 04:55 AstraZeneca CEO Soriot Speaks on $6.9 Billion Cancer Therapy Deal 04:11 AstraZeneca CEO Pascal Soriot on progress on pancreatic cancer 24:42 Our CEO Pascal Soriot features in 'The CNBC Conversation' 03:46 Pharma industry has a trust issue, AstraZeneca CEO says | CNBC Conversation 02:42 AstraZeneca 'within striking distance' of curing some cancers, CEO says | CNBC Conversation 24:07 Bloomberg Turnaround: AstraZeneca 41:15 The Coronavirus vaccine could be ready by the end of 2020, AstraZeneca CEO Pascal Soriot at Tortoise 03:39 CEO Series: Pascal Soriot 03:00 AstraZeneca’s Pascal Soriot Was The Hottest CEO In Pharma Now He’s In 01:56 Pascal Soriot of AstraZeneca on the 2017 HBA Woman of the Year red carpet 06:55 Astrazeneca CEO on Climate Change, China, Drug Industry Challenges More results